• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Envista Holdings Corporation

    2/18/26 4:25:33 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care
    Get the next $NVST alert in real time by email
    S-8 POS 1 nvst-formsx8posfebruary202.htm S-8 POS Document

    As filed with the Securities and Exchange Commission on February 18, 2026
    Registration No. 333-233810
    Registration No. 333-262985
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549  
     
    POST-EFFECTIVE AMENDMENT NO. 2 (333-233810)
    POST-EFFECTIVE AMENDMENT NO. 1 (333-262985)
    TO
    FORM S-8
    REGISTRATION STATEMENT
    UNDER
    THE SECURITIES ACT OF 1933  
     
    envistalogoa25a.jpg
    ENVISTA HOLDINGS CORPORATION
    (Exact Name of Registrant As Specified In Its Charter)  
     
    Delaware83-2206728
    (State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification Number)
    200 S. Kraemer Blvd., Building E92821-6208
    Brea,California
    (Address of Principal Executive Offices)(Zip Code)
    Envista Holdings Corporation Savings Plan
    (Full Title of the Plan)
    Heather L. Turner
    Vice President, Assistant General Counsel, Corporate Securities and Governance
    Envista Holdings Corporation
    200 S. Kraemer Blvd., Building E, Brea, California 92821
    (714) 817-7000
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
     
    Copies to:
    Lori B. Metrock
    Maynard Nexsen PC
    1901 Sixth Ave. N, Suite 1700
    Birmingham, AL 35203
    (205) 254-1000
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  



    Large accelerated filer ☒  Accelerated filer ☐
    Non-accelerated filer ☐  Smaller reporting company ☐
       Emerging growth company ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐




    EXPLANATORY NOTE – DEREGISTRATION OF SECURITIES

    Envista Holdings Corporation (the “Company”) is filing these post-effective amendments (these “Post-Effective Amendments”) to the following registration statements on Form S-8 (together, the “Registration Statements”), which have been previously filed with the Securities and Exchange Commission (the “Commission”), to deregister any and all of the following securities of the Company that were registered but that remained unsold or otherwise unissued under each such Registration Statement as of the date hereof:

    •Registration Statement No. 333-233810, filed with the Commission on September 17, 2019, registering (among other securities) 500,000 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”) and an indeterminate amount of plan interests under the Envista Holdings Corporation Savings Plan (the “Plan”) and the Envista Holdings Corporation Union Savings Plan (the “Union Plan”), as amended by Post-Effective Amendment No.1 filed with the Commission on June 16, 2021, which deregistered all shares of Common Stock and associated plan interests under the Union Plan that remained unissued and unsold as of September 28, 2020, which was the effective date of the merger of the Union Plan into the Plan (but did not deregister the shares of Common Stock and associated plan interests registered under the Plan).

    •Registration Statement No. 333-262985, filed with the Commission on February 24, 2022, registering (among other securities) an additional 1,500,000 shares of Common Stock and an indeterminate amount of plan interests under the Plan.

    As of November 18, 2025, the Plan no longer offers the Company’s Common Stock as an investment option under the Plan. Accordingly, pursuant to the undertaking contained in each Registration Statement to remove from registration, by means of a post-effective amendment, any of the securities that had been registered which remained unsold at the termination of the offering, the Company is filing these Post-Effective Amendments to the Registration Statements to deregister all of the securities, including all plan interests, previously registered under such Registration Statements that remain unsold and unissued under the Plan as of the date hereof. These Post-Effective Amendments do not deregister the shares of Common Stock, associated plan interests or deferred compensation obligations registered under the Envista Holdings Corporation 2019 Omnibus Incentive Plan, as amended, or the Envista Holdings Corporation Deferred Compensation Plan, as amended and restated.




    SIGNATURES

    The Registrant. Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Brea, State of California, on February 18, 2026.
     
      ENVISTA HOLDINGS CORPORATION
      By: /s/ Eric Hammes
       Eric Hammes
       Senior Vice President & Chief Financial Officer

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Paul Keel and Eric Hammes, and each of them, with full power of substitution, such person’s true and lawful attorneys-in-fact and agents for such person, with full power and authority to do any and all acts and things and to execute any and all instruments which said attorneys and agents determine may be necessary or advisable or required to comply with the Securities Act and any rules or regulations or requirements of the Commission in connection with these Post-Effective Amendments to the Registration Statements. Without limiting the generality of the foregoing power and authority, the powers granted include the power and authority to sign the names of the undersigned officers and directors in the capacities indicated below to these Post-Effective Amendments to the Registration Statements, to any and all amendments, both pre-effective and post-effective, and supplements to these Post-Effective Amendments to the Registration Statements, and to any and all instruments or documents filed as part of or in conjunction with these Post-Effective Amendments to the Registration Statements or amendments or supplements thereof, and each of the undersigned hereby ratifies and confirms that said attorneys and agents shall do or cause to be done by virtue hereof. This Power of Attorney may be signed in several counterparts.

    Pursuant to the requirements of the Securities Act, these Post-Effective Amendments to the Registration Statements have been signed by the following persons in the capacities and on the dates indicated:
     



    Signature  Title Date
    /s/ PAUL KEEL
    Paul Keel
      
    President, Chief Executive Officer
    (Principal Executive Officer) and Director
     February 18, 2026
    /s/ ERIC HAMMES
    ERic Hammes
      
    Senior Vice President and Chief Financial Officer
    (Principal Financial Officer)
     February 18, 2026
    /s/ FAEZ KAABI
    Faez Kaabi
      
    Vice President and Chief Accounting Officer
    (Principal Accounting Officer)
     February 18, 2026
    /s/ SCOTT HUENNEKENS
    Scott Huennekens
      Chairman of the Board February 18, 2026
    /s/ WENDY CARRUTHERS
    Wendy Carruthers
      Director February 18, 2026
    /s/ KIERAN T. GALLAHUE
    Kieran T. Gallahue
      Director February 18, 2026
    /s/ VIVEK JAIN
    Vivek Jain
      Director February 18, 2026
    /s/ JAMES ANDREW PIERCE
    James Andrew Pierce
      Director February 18, 2026
    /s/ DANIEL A. RASKAS
    Daniel A. Raskas
      Director February 18, 2026
    /s/ CHRISTINE TSINGOS
    Christine Tsingos
      Director February 18, 2026



    The Plan. Pursuant to the requirements of the Securities Act of 1933, the trustees (or other persons who administer the employee benefit plan) have duly caused these Post-Effective Amendments to the Registration Statements on Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Brea, State of California, on February 18, 2026.
     
      ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
    GLOBAL BENEFITS COMMITTEE, AS ADMINISTRATOR OF THE ENVISTA HOLDINGS CORPORATION SAVINGS PLAN
      By: /s/ TONY BOUSQUETTE
      Name: Tony Bousquette
      Title: 
    Member of the Global Benefits Committee

    Get the next $NVST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NVST

    DatePrice TargetRatingAnalyst
    2/6/2026$35.00Market Perform → Outperform
    Leerink Partners
    12/9/2025$24.00Overweight
    Barclays
    5/27/2025$23.00Neutral → Outperform
    Robert W. Baird
    12/4/2024$20.00Underperform
    Mizuho
    10/31/2024$16.00 → $23.00Underperform → Market Perform
    Leerink Partners
    10/8/2024$20.00Equal Weight
    Wells Fargo
    8/8/2024$23.00 → $16.00Overweight → Neutral
    JP Morgan
    4/26/2024$33.00 → $21.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $NVST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Envista upgraded by Leerink Partners with a new price target

    Leerink Partners upgraded Envista from Market Perform to Outperform and set a new price target of $35.00

    2/6/26 8:05:48 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Envista with a new price target

    Barclays initiated coverage of Envista with a rating of Overweight and set a new price target of $24.00

    12/9/25 8:46:01 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Envista from Neutral to Outperform and set a new price target of $23.00

    5/27/25 9:05:49 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Strategy & Bus. Dev. Reis Mischa exercised 9,675 shares at a strike of $17.25 and sold $290,250 worth of shares (9,675 units at $30.00) (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/11/26 5:15:57 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Keel Paul A

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/3/26 9:04:09 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Financial Officer Hammes Eric D.

    4 - Envista Holdings Corp (0001757073) (Issuer)

    2/3/26 9:04:15 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Keel Paul A bought $506,100 worth of shares (30,000 units at $16.87), increasing direct ownership by 8% to 402,605 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    8/14/24 4:40:20 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Chief Financial Officer Hammes Eric D. bought $400,608 worth of shares (24,532 units at $16.33) (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    8/13/24 6:01:10 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Conley Eric bought $50,015 worth of shares (2,185 units at $22.89), increasing direct ownership by 5% to 47,376 units (SEC Form 4)

    4 - Envista Holdings Corp (0001757073) (Issuer)

    11/20/23 5:49:32 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Envista Reports Fourth Quarter 2025 Results

    BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO.  "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025.  In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee d

    2/5/26 4:05:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Schedules Fourth Quarter 2025 Earnings Call

    BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y

    1/8/26 4:20:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista to Present at the 44th Annual J.P. Morgan Healthcare Conference

    BREA, Calif., Jan. 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 12, 2026, from 3:45 – 4:25 pm PST.  A live audio webcast of the event will be available in the Investors section of the Envista website at https://investors.envistaco.com/. Additionally, a replay of the webcast will be available on the Envista website for 30 days following the presentation. ABOUT ENVISTA HOLDINGS CORPORATION Envista

    1/7/26 4:15:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    SEC Filings

    View All

    SEC Form S-8 POS filed by Envista Holdings Corporation

    S-8 POS - Envista Holdings Corp (0001757073) (Filer)

    2/18/26 4:25:33 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form S-8 POS filed by Envista Holdings Corporation

    S-8 POS - Envista Holdings Corp (0001757073) (Filer)

    2/18/26 4:23:26 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Envista Holdings Corporation

    10-K - Envista Holdings Corp (0001757073) (Filer)

    2/12/26 4:18:39 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Leadership Updates

    Live Leadership Updates

    View All

    QuidelOrtho Announces Appointment of Two Independent Directors to its Board

    Veteran Healthcare CEOs John R. Chiminski and R. Scott Huennekens Bring Deep Industry Experience, Operational Expertise and Financial Acumen to the QuidelOrtho Board QuidelOrtho Corporation (NASDAQ:QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced the appointments of John R. Chiminski and R. Scott Huennekens to its board of directors (the "Board"), effective December 6, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241210769572/en/R. Scott Huennekens (Photo: Business Wire) T

    12/10/24 7:00:00 AM ET
    $CTLT
    $HYPR
    $NVST
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Compass Diversified Announces Stephen Keller as Chief Financial Officer

    WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE:CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that Stephen Keller has been appointed as the Company's Chief Financial Officer (CFO), effective August 31, 2024. He will be replacing Ryan Faulkingham, who has served as the Company's CFO since July 2013 and is departing the Company effective August 30, 2024. Mr. Faulkingham will continue to serve in an advisory capacity in order to facilitate a seamless transition. In his new role, Mr. Keller will lead CODI's finance organization, including accounting, planning, treasury, tax, reporting, and investor relations. He b

    8/26/24 6:00:00 AM ET
    $AVY
    $CODI
    $NVST
    Containers/Packaging
    Consumer Discretionary
    Home Furnishings
    Medical/Dental Instruments

    Envista Holdings Corporation Announces Key Leadership Appointments

    BREA, Calif., July 15, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced the following key leadership appointments: Eric Hammes joins Envista as Chief Financial OfficerStefan Nilsson joins Envista as President, Nobel BiocareVeronica Acurio joins Envista as President, Ormco"It is a pleasure to welcome this trio of successful leaders to Envista," said Paul Keel, Chief Executive Officer. "Each brings experience in dental along with a proven track record of continuous improvement, leading with purpose, and creating value for all stakeholders. Today's an

    7/15/24 4:10:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Financials

    Live finance-specific insights

    View All

    Envista Reports Fourth Quarter 2025 Results

    BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO.  "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025.  In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee d

    2/5/26 4:05:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Schedules Fourth Quarter 2025 Earnings Call

    BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.  The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. Y

    1/8/26 4:20:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    Envista Reports Third Quarter 2025 Results

    BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE:NVST) today announced results for the quarter ended September 26, 2025. This was another strong quarter for Envista"This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations," said Paul Keel, CEO. "We delivered positive growth in all major businesses and once again captured share with Spark aligners, while also turning to profitability in the business. My thanks to our teams around the world for making all this progress possible." Fina

    10/29/25 8:28:00 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    $NVST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Envista Holdings Corporation

    SC 13G - Envista Holdings Corp (0001757073) (Subject)

    11/8/24 12:09:03 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Envista Holdings Corporation (Amendment)

    SC 13G/A - Envista Holdings Corp (0001757073) (Subject)

    2/15/24 10:19:33 AM ET
    $NVST
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Envista Holdings Corporation

    SC 13G - Envista Holdings Corp (0001757073) (Subject)

    2/14/24 4:08:38 PM ET
    $NVST
    Medical/Dental Instruments
    Health Care